Trends and Characteristics of US Medicare Spending on Repository Corticotropin

Daniel M Hartung; Kirbee Johnston; Shelby Van Leuven; Atul Deodhar; David M Cohen; Dennis N Bourdette

doi:10.1001/jamainternmed.2017.3631

Trends and Characteristics of US Medicare Spending on Repository Corticotropin

JAMA Intern Med. 2017 Nov 1;177(11):1680-1682. doi: 10.1001/jamainternmed.2017.3631.

Authors

Daniel M Hartung¹, Kirbee Johnston¹, Shelby Van Leuven², Atul Deodhar³, David M Cohen⁴, Dennis N Bourdette^{2

5}

Affiliations

¹ College of Pharmacy, Oregon State University/Oregon Health & Science University, Portland.
² Department of Neurology, Oregon Health & Science University, Portland.
³ Division of Arthritis & Rheumatic Diseases, Department of Medicine, Oregon Health & Science University, Portland.
⁴ Division of Nephrology and Hypertension, Department of Medicine, Oregon Health & Science University, Portland.
⁵ MS Center of Excellence-West, VA Portland Health Care System, Portland, Oregon.

Abstract

This study uses Medicare Drug Spending Dashboard data to estimate the cost of repository corticotropin to the Medicare program and assess its within-specialty prescribing patterns.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adrenocorticotropic Hormone / administration & dosage
Adrenocorticotropic Hormone / economics*
Drug Repositioning / economics*
Health Expenditures / trends*
Humans
Medicare / trends*
Practice Patterns, Physicians' / economics
Practice Patterns, Physicians' / statistics & numerical data*
United States

Substances

Adrenocorticotropic Hormone